Loading…
Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa
Dyslipidaemia, an irregular aggregate of lipids in the blood is common in diabetes and cardiovascular disease sufferers. A cross-sectional study on the prevalence of dyslipidaemia was performed among type 2 diabetes mellitus (T2DM) patients in the Western Cape, South Africa. Patients ( = 100) that p...
Saved in:
Published in: | International journal of environmental research and public health 2020-11, Vol.17 (23), p.8735 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143 |
---|---|
cites | cdi_FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143 |
container_end_page | |
container_issue | 23 |
container_start_page | 8735 |
container_title | International journal of environmental research and public health |
container_volume | 17 |
creator | Omodanisi, Elizabeth I Tomose, Yibanathi Okeleye, Benjamin I Ntwampe, Seteno K O Aboua, Yapo G |
description | Dyslipidaemia, an irregular aggregate of lipids in the blood is common in diabetes and cardiovascular disease sufferers. A cross-sectional study on the prevalence of dyslipidaemia was performed among type 2 diabetes mellitus (T2DM) patients in the Western Cape, South Africa. Patients (
= 100) that participated in the study were within the age range of 19-68 years, of whom 89% were observed to have serum lipid abnormalities. Out of the 100 patients, 56%, 64%, 61%, and 65% were recorded to have high total cholesterol (TC), hypertriglycemia, increased low-density lipoproteins cholesterol (LDL-C), and reduced high-density lipoproteins cholesterol (HDL-C), respectively. In male diabetic patients, a marked prevalence of (94%) dyslipidemia was noted, of which 52% were affected by high TC (5.3-7.9 mmol/L), with 70% having a high level of triglyceride (TG) [1.72-7.34 mmol/L], while 60% had a high LDL-C (3.1-5.5 mmol/L), including 78% with low HDL-C (0.7-1.1 mmol/L). In comparison, 84% of diabetic females had dyslipidemia, with high TC (5.1-8.1 mmol/L), hypertriglycemia (1.73-8.63 mmol/L), high LDL-C (3.1-5.6 mmol/L), and low levels of HDL-C (0.8-1.1 mmol/L) affecting 60%, 58%, 62%, and 52% of the patients, respectively. This study showed the importance of screening and the regular surveillance of dyslipidaemia in T2DM patients as there is a paucity of data on it in Africa. |
doi_str_mv | 10.3390/ijerph17238735 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7734575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2466036237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143</originalsourceid><addsrcrecordid>eNpdkctLxDAQxoMovq8eJeDFg6tNJ2naiyDrExQFFY8hTSdulrapSSvsf28XH6inGZjffMw3HyF7LDkGKJITN8fQzZhMIZcgVsgmy7JkwrOErf7qN8hWjPMkgZxnxTrZAEiF4EJsEnwI-K5rbA1Sb-n5Itauc5XGxmmqG9--0qdFhzSl506X2GOkd1jXrh8ifdC9w7aP1LW0nyF9wdhjaOlUd3hEH_3Qz-iZDc7oHbJmdR1x96tuk-fLi6fp9eT2_upmenY7MZzl_SSzhbU8Ry5MVokSSl4UVSmERgNpwrgsDVRaphUYFFUOpkQAgdxKtKgZh21y-qnbDWWDlRmvC7pWXXCNDgvltVN_J62bqVf_rqQELqQYBQ6_BIJ_G0Y_qnHRjIZ1i36IKuXjSyFLQY7owT907ofQjvaWlGBZnvOl4PEnZYKPMaD9OYYlapmg-pvguLD_28IP_h0ZfADP1pmC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2465168845</pqid></control><display><type>article</type><title>Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Omodanisi, Elizabeth I ; Tomose, Yibanathi ; Okeleye, Benjamin I ; Ntwampe, Seteno K O ; Aboua, Yapo G</creator><creatorcontrib>Omodanisi, Elizabeth I ; Tomose, Yibanathi ; Okeleye, Benjamin I ; Ntwampe, Seteno K O ; Aboua, Yapo G</creatorcontrib><description>Dyslipidaemia, an irregular aggregate of lipids in the blood is common in diabetes and cardiovascular disease sufferers. A cross-sectional study on the prevalence of dyslipidaemia was performed among type 2 diabetes mellitus (T2DM) patients in the Western Cape, South Africa. Patients (
= 100) that participated in the study were within the age range of 19-68 years, of whom 89% were observed to have serum lipid abnormalities. Out of the 100 patients, 56%, 64%, 61%, and 65% were recorded to have high total cholesterol (TC), hypertriglycemia, increased low-density lipoproteins cholesterol (LDL-C), and reduced high-density lipoproteins cholesterol (HDL-C), respectively. In male diabetic patients, a marked prevalence of (94%) dyslipidemia was noted, of which 52% were affected by high TC (5.3-7.9 mmol/L), with 70% having a high level of triglyceride (TG) [1.72-7.34 mmol/L], while 60% had a high LDL-C (3.1-5.5 mmol/L), including 78% with low HDL-C (0.7-1.1 mmol/L). In comparison, 84% of diabetic females had dyslipidemia, with high TC (5.1-8.1 mmol/L), hypertriglycemia (1.73-8.63 mmol/L), high LDL-C (3.1-5.6 mmol/L), and low levels of HDL-C (0.8-1.1 mmol/L) affecting 60%, 58%, 62%, and 52% of the patients, respectively. This study showed the importance of screening and the regular surveillance of dyslipidaemia in T2DM patients as there is a paucity of data on it in Africa.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph17238735</identifier><identifier>PMID: 33255455</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abnormalities ; Adult ; Aged ; Cardiovascular disease ; Cardiovascular diseases ; Cholesterol ; Cholesterol, HDL ; Cross-Sectional Studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Dyslipidemia ; Dyslipidemias - epidemiology ; Fasting ; Female ; Glucose ; Hemoglobin ; High density lipoprotein ; Humans ; Insulin ; Laboratories ; Lipids ; Lipoproteins ; Liver ; Low density lipoprotein ; Male ; Metabolic disorders ; Metabolism ; Middle Aged ; Plasma ; Population ; Prevalence ; South Africa - epidemiology ; Triglycerides ; Weight control ; Young Adult</subject><ispartof>International journal of environmental research and public health, 2020-11, Vol.17 (23), p.8735</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143</citedby><cites>FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143</cites><orcidid>0000-0003-2707-837X ; 0000-0002-9970-1178 ; 0000-0001-7725-5536</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2465168845/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2465168845?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33255455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Omodanisi, Elizabeth I</creatorcontrib><creatorcontrib>Tomose, Yibanathi</creatorcontrib><creatorcontrib>Okeleye, Benjamin I</creatorcontrib><creatorcontrib>Ntwampe, Seteno K O</creatorcontrib><creatorcontrib>Aboua, Yapo G</creatorcontrib><title>Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa</title><title>International journal of environmental research and public health</title><addtitle>Int J Environ Res Public Health</addtitle><description>Dyslipidaemia, an irregular aggregate of lipids in the blood is common in diabetes and cardiovascular disease sufferers. A cross-sectional study on the prevalence of dyslipidaemia was performed among type 2 diabetes mellitus (T2DM) patients in the Western Cape, South Africa. Patients (
= 100) that participated in the study were within the age range of 19-68 years, of whom 89% were observed to have serum lipid abnormalities. Out of the 100 patients, 56%, 64%, 61%, and 65% were recorded to have high total cholesterol (TC), hypertriglycemia, increased low-density lipoproteins cholesterol (LDL-C), and reduced high-density lipoproteins cholesterol (HDL-C), respectively. In male diabetic patients, a marked prevalence of (94%) dyslipidemia was noted, of which 52% were affected by high TC (5.3-7.9 mmol/L), with 70% having a high level of triglyceride (TG) [1.72-7.34 mmol/L], while 60% had a high LDL-C (3.1-5.5 mmol/L), including 78% with low HDL-C (0.7-1.1 mmol/L). In comparison, 84% of diabetic females had dyslipidemia, with high TC (5.1-8.1 mmol/L), hypertriglycemia (1.73-8.63 mmol/L), high LDL-C (3.1-5.6 mmol/L), and low levels of HDL-C (0.8-1.1 mmol/L) affecting 60%, 58%, 62%, and 52% of the patients, respectively. This study showed the importance of screening and the regular surveillance of dyslipidaemia in T2DM patients as there is a paucity of data on it in Africa.</description><subject>Abnormalities</subject><subject>Adult</subject><subject>Aged</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cholesterol</subject><subject>Cholesterol, HDL</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Dyslipidemia</subject><subject>Dyslipidemias - epidemiology</subject><subject>Fasting</subject><subject>Female</subject><subject>Glucose</subject><subject>Hemoglobin</subject><subject>High density lipoprotein</subject><subject>Humans</subject><subject>Insulin</subject><subject>Laboratories</subject><subject>Lipids</subject><subject>Lipoproteins</subject><subject>Liver</subject><subject>Low density lipoprotein</subject><subject>Male</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Plasma</subject><subject>Population</subject><subject>Prevalence</subject><subject>South Africa - epidemiology</subject><subject>Triglycerides</subject><subject>Weight control</subject><subject>Young Adult</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkctLxDAQxoMovq8eJeDFg6tNJ2naiyDrExQFFY8hTSdulrapSSvsf28XH6inGZjffMw3HyF7LDkGKJITN8fQzZhMIZcgVsgmy7JkwrOErf7qN8hWjPMkgZxnxTrZAEiF4EJsEnwI-K5rbA1Sb-n5Itauc5XGxmmqG9--0qdFhzSl506X2GOkd1jXrh8ifdC9w7aP1LW0nyF9wdhjaOlUd3hEH_3Qz-iZDc7oHbJmdR1x96tuk-fLi6fp9eT2_upmenY7MZzl_SSzhbU8Ry5MVokSSl4UVSmERgNpwrgsDVRaphUYFFUOpkQAgdxKtKgZh21y-qnbDWWDlRmvC7pWXXCNDgvltVN_J62bqVf_rqQELqQYBQ6_BIJ_G0Y_qnHRjIZ1i36IKuXjSyFLQY7owT907ofQjvaWlGBZnvOl4PEnZYKPMaD9OYYlapmg-pvguLD_28IP_h0ZfADP1pmC</recordid><startdate>20201124</startdate><enddate>20201124</enddate><creator>Omodanisi, Elizabeth I</creator><creator>Tomose, Yibanathi</creator><creator>Okeleye, Benjamin I</creator><creator>Ntwampe, Seteno K O</creator><creator>Aboua, Yapo G</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2707-837X</orcidid><orcidid>https://orcid.org/0000-0002-9970-1178</orcidid><orcidid>https://orcid.org/0000-0001-7725-5536</orcidid></search><sort><creationdate>20201124</creationdate><title>Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa</title><author>Omodanisi, Elizabeth I ; Tomose, Yibanathi ; Okeleye, Benjamin I ; Ntwampe, Seteno K O ; Aboua, Yapo G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abnormalities</topic><topic>Adult</topic><topic>Aged</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cholesterol</topic><topic>Cholesterol, HDL</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Dyslipidemia</topic><topic>Dyslipidemias - epidemiology</topic><topic>Fasting</topic><topic>Female</topic><topic>Glucose</topic><topic>Hemoglobin</topic><topic>High density lipoprotein</topic><topic>Humans</topic><topic>Insulin</topic><topic>Laboratories</topic><topic>Lipids</topic><topic>Lipoproteins</topic><topic>Liver</topic><topic>Low density lipoprotein</topic><topic>Male</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Plasma</topic><topic>Population</topic><topic>Prevalence</topic><topic>South Africa - epidemiology</topic><topic>Triglycerides</topic><topic>Weight control</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Omodanisi, Elizabeth I</creatorcontrib><creatorcontrib>Tomose, Yibanathi</creatorcontrib><creatorcontrib>Okeleye, Benjamin I</creatorcontrib><creatorcontrib>Ntwampe, Seteno K O</creatorcontrib><creatorcontrib>Aboua, Yapo G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Omodanisi, Elizabeth I</au><au>Tomose, Yibanathi</au><au>Okeleye, Benjamin I</au><au>Ntwampe, Seteno K O</au><au>Aboua, Yapo G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa</atitle><jtitle>International journal of environmental research and public health</jtitle><addtitle>Int J Environ Res Public Health</addtitle><date>2020-11-24</date><risdate>2020</risdate><volume>17</volume><issue>23</issue><spage>8735</spage><pages>8735-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Dyslipidaemia, an irregular aggregate of lipids in the blood is common in diabetes and cardiovascular disease sufferers. A cross-sectional study on the prevalence of dyslipidaemia was performed among type 2 diabetes mellitus (T2DM) patients in the Western Cape, South Africa. Patients (
= 100) that participated in the study were within the age range of 19-68 years, of whom 89% were observed to have serum lipid abnormalities. Out of the 100 patients, 56%, 64%, 61%, and 65% were recorded to have high total cholesterol (TC), hypertriglycemia, increased low-density lipoproteins cholesterol (LDL-C), and reduced high-density lipoproteins cholesterol (HDL-C), respectively. In male diabetic patients, a marked prevalence of (94%) dyslipidemia was noted, of which 52% were affected by high TC (5.3-7.9 mmol/L), with 70% having a high level of triglyceride (TG) [1.72-7.34 mmol/L], while 60% had a high LDL-C (3.1-5.5 mmol/L), including 78% with low HDL-C (0.7-1.1 mmol/L). In comparison, 84% of diabetic females had dyslipidemia, with high TC (5.1-8.1 mmol/L), hypertriglycemia (1.73-8.63 mmol/L), high LDL-C (3.1-5.6 mmol/L), and low levels of HDL-C (0.8-1.1 mmol/L) affecting 60%, 58%, 62%, and 52% of the patients, respectively. This study showed the importance of screening and the regular surveillance of dyslipidaemia in T2DM patients as there is a paucity of data on it in Africa.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33255455</pmid><doi>10.3390/ijerph17238735</doi><orcidid>https://orcid.org/0000-0003-2707-837X</orcidid><orcidid>https://orcid.org/0000-0002-9970-1178</orcidid><orcidid>https://orcid.org/0000-0001-7725-5536</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-4601 |
ispartof | International journal of environmental research and public health, 2020-11, Vol.17 (23), p.8735 |
issn | 1660-4601 1661-7827 1660-4601 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7734575 |
source | Publicly Available Content Database; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Abnormalities Adult Aged Cardiovascular disease Cardiovascular diseases Cholesterol Cholesterol, HDL Cross-Sectional Studies Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Dyslipidemia Dyslipidemias - epidemiology Fasting Female Glucose Hemoglobin High density lipoprotein Humans Insulin Laboratories Lipids Lipoproteins Liver Low density lipoprotein Male Metabolic disorders Metabolism Middle Aged Plasma Population Prevalence South Africa - epidemiology Triglycerides Weight control Young Adult |
title | Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A20%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Dyslipidaemia%20among%20Type%202%20Diabetes%20Mellitus%20Patients%20in%20the%20Western%20Cape,%20South%20Africa&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Omodanisi,%20Elizabeth%20I&rft.date=2020-11-24&rft.volume=17&rft.issue=23&rft.spage=8735&rft.pages=8735-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph17238735&rft_dat=%3Cproquest_pubme%3E2466036237%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-6f9ff48e45c6d5b3b499db55aec320147bc3da72d3ce5d83cbe335e4f7efea143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2465168845&rft_id=info:pmid/33255455&rfr_iscdi=true |